Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists
Kuhn, B., Hilpert, H., Benz, J., Binggeli, A., Grether, U., Humm, R., Meyer, M., Mohr, P.(2006) Bioorg Med Chem Lett 16: 4016-4020
- PubMed: 16737814 
- DOI: https://doi.org/10.1016/j.bmcl.2006.05.007
- Primary Citation of Related Structures:  
2GTK - PubMed Abstract: 
In the quest for novel PPARalpha/gamma co-agonists as putative drugs for the treatment of type 2 diabetes and dyslipidemia, we have used a structure-based design approach to identify propionic acids with a 1,5-disubstituted indole scaffold as potent PPARalpha/gamma activators. Compounds 13, 24, and 28 are examples of submicromolar dual agonists with different alpha/gamma EC50 ratios that are selective against the delta-isoform. Analysis of the X-ray complex structure of PPARgamma with the indole propionic acid 13 provides a rationalization for some of the observed SAR.
Organizational Affiliation: 
F. Hoffmann-La Roche Ltd, Discovery Research Basel, CH-4070 Basel, Switzerland. bernd.kuhn@roche.com